CALL/AMGEN/450/0.1/21.06.24 | Market Closed - BOERSE MUENCHEN 11:56:50 17/05/2024 pm IST | ||
| 0.011 EUR | +22.22% |
|
| Current month | +37.50% | ||
| 1 month | -15.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 0.011 | +22.22% |
| 16/24/16 | 0.009 | -30.77% |
| 15/24/15 | 0.013 | 0.00% |
| 14/24/14 | 0.013 | +30.00% |
| 13/24/13 | 0.01 | -16.67% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 11:56 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GQ5XCT |
| ISIN | DE000GQ5XCT0 |
| Date issued | 22/09/2023 |
| Strike | 450 $ |
| Maturity | 21/06/2024 (35 Days) |
| Parity | 10 : 1 |
| Emission price | 0.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.064 € |
|---|---|
| Lowest since issue | 0.004 € |
| Spread | 0.07 € |
| Spread % | 90.91% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Warrants
- Warrant
